Telogen Effluvium and COVID-19: A Case and a Brief Review of Literature

    November 2022 in “ Medicina ”
    Francisco Kleyton Zacarias Florêncio, Maiza de Oliveira Tenório, Sandro Gonçalves de Lima
    Studysummary This case report describes post-COVID-19 telogen effluvium in a 39-year-old patient, suggesting that COVID-19 may trigger significant hair loss as a late symptom.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on revistas.usp.br →
    Discuss this study in the Community →

    Related research 4

    1. Hair Loss Pharmacy Today · 2021
    2. Hair Loss: Causes and Pathology International Journal of Research in Medical Sciences & Technology · 2021
    3. Diffuse Hair Loss Elsevier eBooks · 2021
    4. A Review on Hair Loss and Damage 2016